Tice A D
Infections Limited, P.S., Tacoma, Wash.
Chemotherapy. 1991;37 Suppl 3:7-10. doi: 10.1159/000238925.
Since 1981 our physicians' office has developed an outpatient parenteral antibiotic therapy programme which has shown advantages in patient care and provided significant cost savings. While we were able to provide any parenteral antibiotic available, the mainstay of our programme was ceftriaxone because of its broad range of activity, safety, and once-daily administration. Two hundred and ninety cases of outpatient ceftriaxone usage were recorded between January 1989 and March 1990. Ceftriaxone was found to be most useful for bone, soft tissue, and gynaecological infections. Not only was it highly clinically successful, but it was safe to use in the twice-weekly monitoring parameters we routinely perform in our office. The use of ceftriaxone alone during the 15-month period accounted for savings of over US $1.2 million compared to the cost of hospitalization during this period.
自1981年以来，我们的医师办公室制定了一项门诊胃肠外抗生素治疗方案，该方案在患者护理方面显示出优势，并节省了大量成本。虽然我们能够提供任何可用的胃肠外抗生素，但由于头孢曲松具有广泛的活性、安全性和每日一次给药的特点，它是我们方案的主要用药。1989年1月至1990年3月期间记录了290例门诊使用头孢曲松的病例。发现头孢曲松对骨骼、软组织和妇科感染最为有用。它不仅在临床上非常成功，而且在我们办公室常规进行的每周两次监测参数下使用是安全的。与在此期间的住院费用相比，在这15个月期间单独使用头孢曲松节省了超过120万美元。
